Amir Reza Hajrasouliha

Dr. Amir Reza Hajrasouliha


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2021 in ACS Omega
Verified
Journal Article
Open access
SYSaeed Yazdani
Saeed Yazdani
ADAli Daneshkhah
Ali Daneshkhah
ADAbolee Diwate
Abolee Diwate
HPHardi Patel
Hardi Patel
JSJoshua Smith
Joshua Smith
AHAmir Reza Hajrasouliha
Amir Reza Hajrasouliha
The synthesis of gold nanoparticles is dependent on both the concentration of trisodium citrate dihydrate and the time that it interacts with tetrachloroauric acid. A wide range of gold nanoparticles with various sizes and dispersity can be produced based on control variables, such as time of reaction and acid concentration, using a similar approach to that of the Turkevich model. In this model, the pH of the solution decreases slightly throughout the reaction (0.005 unit/min) due to the chemical interactions between trisodium citrate dihydrate and tetrachloroauric acid. Dicarboxy acetone is formed during citrate oxidization, resulting in gold nuclei formation over time. In addition, gold nanoparticle nucleation causes pH fluctuation over time based on gold nanoparticle sizes. An inverse correlation (coefficient of smaller than −0.97) was calculated between the pH and reaction time at different ratios of trisodium citrate dihydrate to tetrachloroauric acid. Regression analysis was used to develop a model for the prediction of the size of gold nanoparticles ranging from 18 to 38 nm based on the concentration of trisodium citrate dihydrate and the reaction time.

29 July 2022 in Survey of Ophthalmology
Verified
Journal Article
Closed access
EKElias Kovoor
Elias Kovoor
SCSunil K. Chauhan
Sunil K. Chauhan
AHAmir Reza Hajrasouliha
Amir Reza Hajrasouliha

1 January 2021 in Therapeutic Advances in Ophthalmology
Verified
Journal Article
Open access
PDF file
MSMelanie Scheive
Melanie Scheive
SYSaeed Yazdani
Saeed Yazdani
AHAmir Reza Hajrasouliha
Amir Reza Hajrasouliha
The clinical application of nanotechnology in medicine is promising for therapeutic, diagnostic, and surgical improvements in the near future. Nanotechnologies in nano-ophthalmology are in the early stages of application in clinical contexts, including ocular drug and gene delivery systems addressing eye disorders, particularly retinopathies. Retinal diseases are challenging to treat as current interventions, such as intravitreal injections, are limited by their invasive nature. This review examines nanotechnological approaches to retinal diseases in a clinical context. Nanotechnology has the potential to transform pharmacological and surgical interventions by overcoming limitations posed by the protective anatomical and physiological barriers that limit access to the retina. Preclinical research in the application of nanoparticles in diagnostics indicates that nanoparticles can enhance existing diagnostic and screening tools to detect diseases earlier and more easily and improve disease progression monitoring precision.

8 July 2024 in Survey of Ophthalmology
Verified
Journal Article
Closed access
ATAli Torkashvand
Ali Torkashvand
AIAfshin Izadian
Afshin Izadian
AHAmir Reza Hajrasouliha
Amir Reza Hajrasouliha

1 October 2022 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
SJSayena Jabbehdari
Sayena Jabbehdari
GYGhasem Yazdanpanah
Ghasem Yazdanpanah
LCLouis B. Cantor
Louis B. Cantor
AHAmir Reza Hajrasouliha
Amir Reza Hajrasouliha
Review Article A narrative review on the association of high intraocular pressure and glaucoma in patients with retinal vein occlusion Sayena Jabbehdari, Ghasem Yazdanpanah, Louis B. Cantor, Amir Reza Hajrasouliha

24 October 2023 in Acta Ophthalmologica
Verified
Journal Article
Closed access
LRLucas W. Rowe
Lucas W. Rowe
ABAditya V Belamkar
Aditya V Belamkar
GAGal Antman
Gal Antman
AHAmir Reza Hajrasouliha
Amir Reza Hajrasouliha
AHAlon Harris
Alon Harris